Showing recent highlights
What's New
PubMed · November 1, 2026
Researchers found that postmenopausal women with osteoporosis — a condition where bones become weak and fragile — responded positively to using a voice-assistant device at home to help manage their condition. The device delivered exercise guidance, nutrition tips, medication reminders, and educational videos, and most participants found it easy to use, appropriate for their needs, and something they could see themselves continuing long-term. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that two common osteoporosis medications — alendronate and risedronate — caused similar rates of stomach and digestive side effects, such as nausea or stomach upset, with alendronate showing a slightly higher rate (about 20%) compared to risedronate (about 18%). For someone with osteoporosis who struggles with digestive discomfort on one of these medications, this might be worth discussing with their doctor, since switching between them could potentially help. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that most people at risk for osteoporosis — about 83% in this study — tend to worry more about the rare side effects of taking a bone-strengthening medication called a bisphosphonate than about the much higher risk of a serious bone fracture from not treating the condition at all. This pattern, where the fear of doing something feels worse than the risk of doing nothing, may be one reason fewer people are choosing to treat their osteoporosis, even when the benefits outweigh the risks. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 29, 2026
Researchers found that a special type of stem cell treatment — where a patient's own stem cells were modified in the lab to better find their way to bones — appeared to reduce broken bones and improve bone strength in a small group of women with advanced osteoporosis (a condition where bones become thin and fragile). The stem cells were given through a single IV drip, and over five years of follow-up, no serious safety problems were reported. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 29, 2026
A study found that certain blood and urine markers — which show how quickly the body is breaking down or building bone — may be much better at detecting whether osteoporosis medication is actually working than the standard bone density scan alone. Researchers found that these bone markers picked up a clear response to medication in about 96% of patients, compared to only 24–47% for bone density scans, suggesting doctors might catch problems with treatment earlier by checking these markers at around 3 months. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 3, 2026
Researchers found that men being treated for prostate cancer — especially those on a hormone-blocking treatment called androgen-deprivation therapy (ADT) — have a notably high rate of bone thinning and osteoporosis (a condition where bones become weak and more likely to break). This matters because weaker bones mean a greater chance of fractures, which can seriously affect quality of life. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
PubMed · October 1, 2026
Researchers found that regular exercise can meaningfully improve balance in people with osteoporosis — a condition where bones become weak and brittle, making falls especially dangerous. The strongest results were seen when people exercised at least 3 times per week, for sessions of 60 minutes or longer, over a period of at least 12 weeks. Better balance can help reduce the risk of falls, which is a serious concern for people with fragile bones.
What's New
PubMed · October 1, 2026
Researchers found that artificial intelligence (AI) tools — computer programs that learn patterns from large amounts of data — may be better at predicting broken bones in people with osteoporosis (a condition that makes bones weak and fragile) than some of the standard tools doctors currently use. AI also showed promise in spotting bone weakness from routine scans that weren't even ordered for that purpose, which could help catch the condition earlier in people who don't know they have it. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 30, 2026
Researchers found that eating a lot of sugar is consistently linked to a higher risk of 18 different health problems, with the strongest evidence connecting sugar intake to type 2 diabetes, obesity, serious heart problems like heart attacks or strokes, and early death. For people with type 2 diabetes especially, this matters because sugar consumption may worsen blood sugar control and raise the chances of complications beyond diabetes alone. This is early research and hasn't yet changed treatment guidelines.
What's New
ScienceDaily · September 21, 2026
A major review of more than 153,000 adults found that taking calcium and vitamin D supplements — either separately or together — did little to prevent broken bones or falls in most older adults, including those with osteoporosis (a condition where bones become weak and fragile). Researchers say this challenges the common habit of routinely recommending these supplements for bone protection, and suggests that approaches like balance and strength training exercises may be more helpful. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient actually needs to keep taking calcium and vitamin D supplements, or whether exercise for balance and strength might be better for preventing broken bones.
What's New
PubMed · September 15, 2026
Researchers found that most studies on osteoporosis — a condition where bones become weaker and more likely to break — have focused mainly on women, so scientists took a closer look at how well certain bone-strengthening medications work specifically for men aged 50 and older. The review looked at several types of medications, including bisphosphonates (common bone-protecting drugs like alendronate), to see how well they prevent broken bones in men, and whether they cause any harmful side effects. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed · September 9, 2026
According to the Taiwanese Association of Diabetes Educators, the Taiwanese Osteoporosis Association, and the Endocrine Society of the Republic of China, people with type 2 diabetes should be screened for osteoporosis (weak, brittle bones) earlier than the general population, because diabetes can quietly weaken bones and raise the risk of fractures even when standard bone-density tests look normal. These guidelines highlight that the usual tools for estimating fracture risk may actually underestimate how vulnerable someone with diabetes really is, so their doctor may need to adjust how that risk is calculated. The guidelines also note that choosing diabetes medications wisely matters for bone health, since some can help protect bones while others may have the opposite effect.
Ask your doctor: Ask the doctor whether the patient should be screened for weak bones early on, since diabetes can affect bone health even when bone density tests look normal.
What's New
PubMed · September 5, 2026
Researchers found that ellagic acid — a natural compound found in foods like pomegranates, berries, and walnuts — may help protect bones by encouraging the growth of bone-building cells while slowing down the cells that break bone down, which is exactly the imbalance that causes osteoporosis (a condition where bones become weak and fragile). These findings come from lab and animal studies, so scientists don't yet know if the same effects would happen in people. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 4, 2026
Researchers found that when people with osteoporosis stop taking a bone-strengthening medication called denosumab, their bones can lose density quickly and their risk of spinal fractures rises sharply — a kind of 'rebound' effect. The study looked at whether taking a different bone medication afterward (specifically drugs like alendronate or zoledronic acid, which work by slowing bone breakdown) could help protect against those fractures, and found that it was linked to a major reduction in spinal fractures compared to taking nothing or a different type of medication. This matters because many people do eventually stop denosumab, and knowing what might come next is an important part of long-term bone care conversations with their doctor. This is early research and hasn't yet changed treatment guidelines.
What's New
ScienceDaily · September 2, 2026
A study following nearly 10,000 older women over 10 years found that drinking tea was linked to slightly stronger hip bones, while drinking more than five cups of coffee a day was linked to weaker bones — though moderate coffee drinking did not appear to be a problem. This matters for people with osteoporosis, a condition where bones become thinner and more fragile over time, because even small changes in bone strength can affect their risk of fractures. This is early research and hasn't yet changed treatment guidelines.
Medications
FDA Drug Approvals · September 2, 2026
Researchers found that alendronate sodium — sold under brand names like Fosamax — is a medication taken by mouth as a liquid solution that is used to help people with osteoporosis, a condition where bones become weak and brittle. A study found this version, made by Precision Dose Inc., has received FDA approval, making it a newly available form of an existing treatment option. This liquid form may be an alternative for people who have difficulty swallowing pills.
Ask your doctor: Ask the doctor whether alendronate sodium might be a good option for the patient to help strengthen bones and prevent breaks from osteoporosis.
What's New
PubMed · September 1, 2026
Researchers found that people with chronic pain conditions — including fibromyalgia, rheumatoid arthritis, and knee or hip osteoarthritis — reported improvements in pain, mental health, and physical functioning after taking capsules containing different combinations of cannabis compounds over 12 weeks. All three formulas tested showed benefits, though none stood out as clearly superior to the others. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
A study found that people with osteoporosis caused by long-term steroid use who switched to a bone-building medication called romosozumab (brand name Evenity) showed slightly greater improvements in bone density compared to those who stayed on their existing bone medications — even though the patients who switched were older and had weaker bones to begin with. Bone density, which measures how strong and solid bones are, improved at several points in the body over 12 months in the romosozumab group. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that roughly 1 in 10 adults studied across Latin America had experienced a fragility fracture — a break in the bone caused by osteoporosis, where bones become weak and brittle. Vertebral fractures, meaning breaks in the small bones of the spine, were the most common type found. This matters because fractures from osteoporosis can lead to serious pain, disability, and even death, and understanding how widespread the problem is in Latin America could help health systems better prepare to support affected patients. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that artificial intelligence (AI) tools trained to read chest X-rays — images already taken for other reasons like checking the lungs — could also detect signs of osteoporosis (a condition that weakens bones and raises the risk of fractures) with reasonable accuracy. This matters because many people with osteoporosis don't know they have it until a bone breaks, and using X-rays that patients are already getting could be a low-cost way to catch it earlier without extra tests. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that people with osteoporosis who take bone-strengthening medications — such as bisphosphonates or denosumab — may face a higher risk of developing a serious jaw condition called osteonecrosis (where the jawbone begins to break down and die) when they have dental implants placed. The risk can be triggered either by the implant surgery itself or simply by having the implant in place over time, which matters because dental implants are very common and many people with osteoporosis take these medications long-term. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient should be concerned about a rare jaw condition called osteonecrosis if the patient is taking Denosumab for osteoporosis and planning to get dental implants.
What's New
PubMed · August 28, 2026
Researchers found that traditional Chinese medicine treatments — including herbal remedies and other practices — may help postmenopausal women with osteoporosis (a condition where bones become weaker and more likely to break) by improving bone density and reducing pain. The analysis looked at hundreds of studies and found meaningful improvements, though the quality and design of those studies varied quite a bit, making it hard to draw firm conclusions. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 18, 2026
Researchers found that a traditional Chinese herbal remedy called Weishen Decoction helped older adults with osteoporosis — a condition where bones become weak and fragile — feel better and showed some early signs of improving bone strength in the hip area, compared to a sugar pill (placebo). About two-thirds of people taking the herbal remedy reported meaningful improvement in back pain and related symptoms, versus about four in ten in the placebo group, and no serious side effects were reported in either group over the 12-week study. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 17, 2026
Researchers found that even when family doctors recognized a fracture as likely caused by weak bones — a warning sign for osteoporosis — many patients still didn't receive follow-up bone scans or treatment. In fact, fewer than half of those patients were started on any bone-strengthening treatment after their fracture. This matters because a fracture from a minor bump or fall can be a signal that bones are fragile, and missing that window for follow-up care may leave people at higher risk for another, potentially more serious break. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed (Guideline Reviews) · August 11, 2026
According to the Chinese Health Risk Management Collaboration-Osteoporosis Group guidelines, people at risk for osteoporosis — a condition where bones become weak and more likely to break — should focus on everyday habits like eating enough calcium and protein, getting vitamin D (through food or sunlight), staying active, maintaining a healthy weight, and avoiding smoking and heavy alcohol use. These recommendations are designed to be practical for the general public, not just doctors, because awareness of bone health in China has been low even as the population ages. The guidelines also outline specific tools their doctor can use to check a person's risk of fractures before problems develop.
What's New
PubMed · August 10, 2026
Researchers found that for middle-aged and older adults with osteoporosis — a condition where bones become weaker and more likely to break — the sweet spot for resistance (weight-based) exercise appears to be moderate intensity three times per week, which was linked to meaningful improvements in bone density at the hip and spine. High-intensity resistance exercise done twice a week also showed strong results for overall body bone density. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that people who take glucocorticoids — a type of steroid medication commonly used to treat conditions like arthritis, asthma, or lupus — tend to have weaker bone quality compared to people who don't take these medications. The study used a measurement called the Trabecular Bone Score (TBS), which looks at the inner texture and strength of bone (not just its density), and found it was consistently lower in steroid users across different sexes, ethnicities, and body types — suggesting that standard bone density scans alone may miss some of the bone-weakening effects of these drugs. For someone with osteoporosis (a condition where bones become thin and fragile and break more easily), this matters because it hints that TBS testing alongside regular bone scans might give a fuller picture of fracture risk. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that a type of 3D dental or medical scan called a cone beam CT (CBCT) — a detailed imaging tool some people get at the dentist or for other reasons — can moderately detect low bone density, which is the main concern in osteoporosis (a condition where bones become weak and fragile). The scan was better at correctly identifying people who did NOT have low bone density than at catching everyone who did, meaning it occasionally missed cases. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 9, 2026
Researchers found that taking potassium citrate — a supplement that helps balance acid levels in the body — may help slow down bone loss in postmenopausal women, at least in the short term. Specifically, after one month, the supplement appeared to reduce a marker in the urine that signals bones are breaking down faster than they're being rebuilt — though this effect wasn't clearly seen at longer time points like 3, 6, or 12 months. For someone with osteoporosis (a condition where bones become weak and fragile), this is an interesting early signal worth watching, but this is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 7, 2026
Researchers found that certain minimally invasive spine procedures — where a doctor uses a needle to stabilize a broken vertebra (a bone in the spine weakened by osteoporosis) — may relieve pain and improve mobility better than others, with some newer techniques ranking highest for both short-term and longer-term pain relief. For people with osteoporosis, spinal fractures are a major cause of ongoing back pain and difficulty moving, so understanding which procedures work best could be meaningful for treatment decisions. This is early research and hasn't yet changed treatment guidelines.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.